We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SFD:NASDAQSmithfield Foods, Inc. Analysis

Data as of 2026-04-30 - not real-time

$26.42

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Smithfield Foods is trading in a technically bullish environment, with the short‑term moving average comfortably above the mid‑term average and both sitting above the long‑term trend line, while momentum indicators sit near the neutral zone and the MACD has turned bearish, suggesting a potential short‑term pullback. Volatility remains elevated and volume is tapering, which could amplify price swings, but the stock’s beta is markedly low, indicating limited market‑wide risk. The dividend yield is attractive for income‑focused investors and the payout ratio sits well below the earnings stream, supporting dividend sustainability. However, a discounted cash‑flow model places intrinsic value well below the current market price, flagging a material overvaluation risk.
Fundamentally, the company delivers steady earnings with modest revenue growth, healthy profit margins, and robust free cash flow that comfortably covers its dividend. The balance sheet shows a manageable debt load and ample liquidity, while the consensus analyst outlook remains a “buy.” Given the defensive consumer‑staples positioning, the stock offers defensive qualities, but investors should monitor for a corrective move toward intrinsic value and weigh the high dividend against the overvalued price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • MACD bearish crossover
  • Decreasing trading volume
  • Price approaching near‑term support

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong free cash flow generation
  • Attractive dividend yield
  • Defensive consumer‑staples sector

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend payout
  • Low systematic risk (beta)
  • Solid balance sheet and cash position

Key Metrics & Analysis

Financial Health

Revenue Growth0.80%
Profit Margin6.49%
P/E Ratio10.3
ROE14.95%
ROA7.29%
Debt/Equity33.30
P/B Ratio1.5
Op. Cash Flow$1.2B
Free Cash Flow$630.4M

Technical Analysis

TrendBullish
RSI40.9
Support$25.74
Resistance$29.81
MA 20$28.62
MA 50$26.21
MA 200$23.98
MACDBearish
VolumeDecreasing
Fear & Greed Index88.46

Valuation

Fair Value$19.69
Target Price$31.36
Upside/Downside18.69%
GradeOvervalued
TypeValue
Dividend Yield4.73%

Risk Assessment

Beta0.31
Volatility36.62%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.